Literature DB >> 12831456

Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.

Anna Bjerre1, Berit Brusletto, Reidun Øvstebø, Gun Britt Joø, Peter Kierulf, Petter Brandtzaeg.   

Abstract

We have examined the in vitro stimulatory effects of lipopolysaccharide (LPS)-containing samples (meningococcal shock plasma, n = 10; non-shock plasma, n = 10; cerebrospinal fluid (CSF), n = 7) before and after immunodepletion of interleukin (IL)-10 in a monocyte target assay. We also studied the stimulatory effects of plasma collected from 3 patients with lethal septicemia caused by Streptococcus pneumoniae without detectable LPS but with 100-fold increased levels of heat-shock protein 70 (HSP70). HSP70 may, like LPS, activate monocytes via the Toll-like receptor 4 (TLR4). The samples were analyzed for LPS, tumor necrosis factor (TNF)-alpha, IL-10 and HSP70; applied on human monocytes (purity > 95%) before and after IL-10 immunodepletion, in the absence or presence of CD14 blocking mAb (60bca) or the lipid A antagonist, Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA) which blocks TLR4. Monocyte activation was measured by increased TNF-alpha secretion and tissue factor (TF) up-regulation by monocyte procoagulant activity (PCA). There was a positive correlation between patient plasma LPS levels (n = 10) and increases in TNF-alpha secretion by the monocytes after immunodepletion of IL-10 (r = 0.82). Pretreatment of the monocytes with mAbCD14 or RsDPLA reduced TNF-alpha secretion to median 5% and 12%, respectively, of the levels before the receptor complex was blocked. The median levels of HSP70 were 543 ng/ml (range, 468-962 ng/ml) in pneumococcal shock plasma, 81.5 ng/ml (range, 41-331 ng/ml) in meningococcal shock plasma and 24 ng/ml (range, < 0.8-41 ng/ml) in meningococcal non-shock plasma. Pneumococcal septic shock plasmas with significantly higher levels of HSP70 (P < 0.05) did not induce TNF-alpha secretion in the monocytes. The results strongly suggest that LPS in meningococcal shock plasma is the major activator of monocytes whereas HSP70 (in plasma concentrations up to 963 ng/ml) does not activate monocytes in this assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831456     DOI: 10.1179/096805103125001559

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  9 in total

1.  MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands.

Authors:  Laura Plant; Hong Wan; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

2.  Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.

Authors:  Reidun Øvstebø; Petter Brandtzaeg; Berit Brusletto; Kari Bente Foss Haug; Knut Lande; Ernst Arne Høiby; Peter Kierulf
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes.

Authors:  Unni Gopinathan; Reidun Ovstebø; Ole Kristoffer Olstad; Berit Brusletto; Hans Christian Dalsbotten Aass; Peter Kierulf; Petter Brandtzaeg; Jens Petter Berg
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

4.  Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains.

Authors:  Reidun Ovstebø; Ole Kristoffer Olstad; Berit Brusletto; Anne Sophie Møller; Audun Aase; Kari Bente Foss Haug; Petter Brandtzaeg; Peter Kierulf
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

5.  Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N. meningitidis.

Authors:  Unni Gopinathan; Kathrine Røe Redalen; Anne-Marie Trøseid; Peter Kierulf; Petter Brandtzaeg; Anne Hansen Ree; Jens Petter Berg; Reidun Øvstebø
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

6.  Transcriptomic data from two primary cell models stimulating human monocytes suggest inhibition of oxidative phosphorylation and mitochondrial function by N. meningitidis which is partially up-regulated by IL-10.

Authors:  Unni Gopinathan; Reidun Øvstebø; Berit Sletbakk Brusletto; Ole Kristoffer Olstad; Peter Kierulf; Petter Brandtzaeg; Jens Petter Berg
Journal:  BMC Immunol       Date:  2017-10-27       Impact factor: 3.615

7.  Traceability and distribution of Neisseria meningitidis DNA in archived post mortem tissue samples from patients with systemic meningococcal disease.

Authors:  Berit Sletbakk Brusletto; Bernt Christian Hellerud; Else Marit Løberg; Ingeborg Løstegaard Goverud; Åshild Vege; Jens Petter Berg; Petter Brandtzaeg; Reidun Øvstebø
Journal:  BMC Clin Pathol       Date:  2017-08-16

8.  Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia.

Authors:  Wude Mihret; Berit Sletbakk Brusletto; Reidun Øvstebø; Anne-Marie Siebke Troseid; Gunnstein Norheim; Yared Merid; Afework Kassu; Workeabeba Abebe; Samuel Ayele; Mezgebu Silamsaw Asres; Lawrence Yamuah; Abraham Aseffa; Beyene Petros; Dominique A Caugant; Petter Brandtzaeg
Journal:  Innate Immun       Date:  2019-04       Impact factor: 2.680

9.  Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis.

Authors:  Philip H C Kremer; John A Lees; Bart Ferwerda; Arie van de Ende; Matthijs C Brouwer; Stephen D Bentley; Diederik van de Beek
Journal:  Front Med (Lausanne)       Date:  2020-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.